MarvelBiome, Inc. operates as a biopharmaceutical company, which engages in harnessing the power of microbes for treating various human diseases. it focuses on isolating, identifying, and characterizing microbial populations for novel therapeutic applications. The company was founded by Gary Ruvkun, Rudolph Emile Tanzi, Priti Chatter, Jothi Amaranath Govindan, and Elamparithi Jayamani and is headquartered in Woburn, MA.

Guangdong Shengpu Life Technology Co., Ltd., established on 2006-10-27, Business scope includes natural science research and experimental development;Life Engineering Project Development;Health Sciences Program Research,to develop;Technology Promotion of Research Results of Health Science Projects;Health Sciences Program Research Transfer;Research and development of biological products(Does not include licensed operations);Biomedical Technology Research;Biotechnology Development Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Research on water treatment equipment,to develop;Technology development and technical services of artificial intelligence algorithm software;AI Hardware Sales;electronic,Communication and Automatic Control Technology Research,to develop;Investment Advisory Services;Energy saving technology development service;Energy-saving technical consultation,communication service;Energy-saving technology transfer service;E-commerce information consultation;Electronic equipment engineering installation service;Special Equipment Sales;high-tech investment,operate(Does not include licensed operations,Projects prohibited by laws and regulations shall not be operated);Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);Internet Merchandise Sales(Except for licensed and approved products);Import and export(Excluding franchised products);Technology Import and Export;

Sapir Pharmaceuticals, Inc. is into developing therapies in Opiate and Cocaine Addiction, withdrawal and relapse, and Novel Pharmaceutical Formulations. The company is headquartered in Lakewood, NJ.

IsoPlexis Corp. engages in the development of curative medicines and personalized therapeutics. Its single cell proteomics platform, which includes instruments, chip consumables and software, provides an end-to-end solution to reveal a more complete view of protein function at an individual cellular level. The company was founded by Sean Mackay, Rong Fan, and Kara K. Brower in March 2013 and is headquartered in Branford, CT.

Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

AstraZeneca UK Ltd. manufactures pharmaceutical products. Its products are used to treat cardiovascular diseases, diabetes, and gastrointestinal infections. The company was founded on November 26, 1998 and is headquartered in London, the United Kingdom.

NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents. NuSirts first product, NS-0100, uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies.

CyDex Pharmaceuticals, Inc., a pharmaceutical company, engages in the development and commercialization of drugs specifically designed to address limitations of current therapies. It develops a portfolio of product candidates utilizing its drug formulation technology using Captisol, a group of cyclodextrins. The company's products include Geodon IM and Abilify Injection IM for bipolar disorder/schizophrenia; Vfend IV for antifungal; and Cerenia for canine motion sickness. It also develops Fosphenytoin IV and IM for status epilepticus; Melphalan IV for multiple myeloma; Topiramate IV for epilepsy; Amiodarone IV for arrhythmia; Budesonide Solution Inhalation for asthma; Clopidogrel IV for atherothrombosis; and Budesonide/Azelastine Nasal Spray for allergic rhinitis. In addition, the company out license its technology to third parties for use in the development of their products. CyDex Pharmaceuticals, Inc. was formerly known as CyDex, Inc. and it changed its name in November 2007. The company was founded in 1993 and is based in Lenexa, Kansas.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission-critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a company that places a high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, they strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic. David R. Walt, Satnam Alag, Larry Bock, and John Stuelpnagel co-founded Illumina in San Diego, California in 1998.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Wudi Huaxin Petroleum Technology Service Co., Ltd., established on 2014-01-09, Business scope includes oil drilling equipment accessories,Downhole tool research and development,design,processing,retail;Drilling Technology Research;Petroleum technology development,transfer,consult,intermediary,Serve;Geological Correlation Analysis,assay,test;Oil well operation technical service(Those that need a license to operate must operate with a valid license,Do not operate if prohibited by national laws and regulations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

LiveLeaf, Inc. is a private company headquartered in San Carlos, CA. The firm operates as a biotechnology company.\nThe company says this about itself: LiveLeaf,Inc. is a San Francisco Bay Area based company advancing novel therapeutics based on a plant immune biochemistry that is target activated by enzymes of the microbiome and damaged mammalian tissue. LiveLeaf��s patented LiveXtract�� technology is the foundation for currently marketed non-pharmaceutical human and livestock health products targeting gastrointestinal stress. The technology has the potential to transform many plant flavonoids and tannins into immunologically potent ingredients. Grazix Animal Health is a LiveLeaf subsidiary producing LiveXtract-based supplements for cost-effective antibiotic-free livestock production through gut barrier optimization. Quellthera is a LiveLeaf subsidiary advancing the LiveXtract technology platform into novel anti-infective drugs that exploit direct and epigenetic suppression of bacterial virulence.

Jiangxi Heze Biotechnology Co., Ltd., established on 2014-03-24, Business scope includes licensed projects:Mixed Feed Additives,Manufacture and sales of additive premixed feed;feed ingredients,Chemical raw materials(Excluding hazardous chemicals)Sales;General cargo import and export trade(Except for national restrictions or prohibitions)*(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Research Development Foundation is an American private company that operates as noncommercial research organizations.

AstraZeneca is an innovation-driven biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines that are innovative, effective, and which offer added benefits such as reduced side effects or better ways of taking the treatment. AstraZeneca focuses on getting the best from every medicine they make by exploring all the ways it can be used or improved. AstraZeneca was established on April 6, 1999, in Cambridgeshire, United Kingdom.

Jiangxi Yongfeng Boyuan Industrial Co., Ltd., established on 1998-06-01, Business scope includesDDSCatalyst series products,DDSCatalyst accessories andBExcipients,Iron salt and chemical raw materials,DDSdust remover,DDSDesulfurizer,DDSDenitrifier;natural extract,Alkaloids;new anticancer drug,Development of biological products;casting,Machine made;Computer hardware and software and automatic control system,Electronic and Telecommunications Equipment,Electrical equipment,Environmental protection equipment manufacturing and technical services,Chemical equipment manufacturing and technical services,new technology,Research on new products and new equipment,Development and Technical Services;Manufacture of chemical pipe fittings and chemical transfer pumps;No.IIIclass low,Manufacturing of medium pressure vessels;Construction General Contracting;Professional contractors;Self-operated and agent import and export business of various commodities and technologies at home and abroad(Except for commodities and technologies that the state restricts the company to operate and prohibits import and export)*** ((Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)